Methacrylic Acid

Methacrylic Acid

SCHEMBL17459015

C=C(C)C(=O)O.CCNN

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.44
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 2/20 0.36
TGFBR1 P36897 1/20 0.34
CTSD P07339 1/20 0.33
FFAR3 O14843 2/20 0.32
THRB P10828 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
TSHR P16473 2/20 0.30
GRIK1 P39086 1/20 0.30
GRIK2 Q13002 1/20 0.30
GRM1 Q13255 1/20 0.30
GRM2 Q14416 1/20 0.30
HSD17B10 Q99714 1/20 0.30
LCK P06239 1/20 0.30
FYN P06241 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL4492710 0.83
Acetic Acid SCHEMBL6449854 0.83 FFAR3 (0.47) ALOX15TDP1ALDH1A1CTSDFFAR3
Oxalic Acid SCHEMBL55207 0.83 ALOX15 (0.59) ALOX15TDP1ALDH1A1CTSDFFAR3
Acetic Acid SCHEMBL7132795 0.83 FFAR3 (0.47) ALOX15TDP1ALDH1A1CTSDFFAR3
Methacrylic Acid SCHEMBL331477 0.81 ALDH1A1 (0.38) ALOX15TDP1ALDH1A1TGFBR1FFAR3
Methacrylic Acid SCHEMBL5514685 0.81 TP53 (0.44) ALOX15TDP1ALDH1A1TGFBR1FFAR3
Acetic Acid SCHEMBL3891856 0.80
Methacrylic Acid SCHEMBL4931388 0.80
Methacrylic Acid SCHEMBL346724 0.80 TDP1 (0.44) TDP1ALDH1A1TGFBR1FFAR3THRB
Methacrylic Acid SCHEMBL2581850 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3172299-B1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS PROCTER & GAMBLE (US) 2019-09-25 EP claimed
US-10407646-B2 Treatment compositions THE PROCTER & GAMBLE COMPANY (US) 2019-09-10 US claimed
US-20190225916-A1 TREATMENT COMPOSITIONS PROCTER & GAMBLE (US) 2019-07-25 US claimed
US-10266792-B2 Treatment compositions THE PROCTER & GAMBLE COMPANY (US) 2019-04-23 US claimed
EP-3172299-A1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS The Procter and Gamble Company (US) 2017-05-31 EP claimed
US-20160032220-A1 TREATMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-02-04 US claimed
WO-2016014733-A1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-01-28 WO claimed
EP-3172299-B1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS PROCTER & GAMBLE (US) 2019-09-25 EP disclosed
US-10407646-B2 Treatment compositions THE PROCTER & GAMBLE COMPANY (US) 2019-09-10 US disclosed
US-20190225916-A1 TREATMENT COMPOSITIONS PROCTER & GAMBLE (US) 2019-07-25 US disclosed
US-10266792-B2 Treatment compositions THE PROCTER & GAMBLE COMPANY (US) 2019-04-23 US disclosed
EP-3172299-A1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS The Procter and Gamble Company (US) 2017-05-31 EP disclosed
US-20160032220-A1 TREATMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-02-04 US disclosed
WO-2016014733-A1 FABRIC AND HOME CARE TREATMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-01-28 WO disclosed